Today: 19 May 2026

Legend Biotech (LEGN) stock slips in premarket after 9% surge as Gilead-Arcellx deal spotlights Carvykti rivals

Legend Biotech (LEGN) stock slips in premarket after 9% surge as Gilead-Arcellx deal spotlights Carvykti rivals

Legend Biotech shares slipped 0.2% to $19.72 in premarket trading Tuesday after a 9% jump the previous session, following news of Gilead’s $7.8 billion deal to buy Arcellx. The acquisition put focus on rival CAR-T therapies, with Arcellx’s anito-cel under FDA review and analysts citing possible safety advantages over Legend’s Carvykti, which generated $1.9 billion in 2025 sales.
24 February 2026
·
Viking Therapeutics stock (VKTX) slips in premarket after 11% rally as Novo obesity-drug stumble hits tape

Viking Therapeutics stock (VKTX) slips in premarket after 11% rally as Novo obesity-drug stumble hits tape

Viking Therapeutics shares fell 0.5% to $34.30 in premarket trading Tuesday after an 11.1% surge Monday, as investors reacted to new obesity drug trial data from Novo Nordisk. Novo’s CagriSema showed less weight loss than Eli Lilly’s rival drug, shaking the sector. Viking plans to advance its oral obesity drug VK2735 into late-stage trials in Q3. Investors await updates at upcoming healthcare conferences in March and April.
24 February 2026
··
Bank of America stock steadies premarket after Monday’s drop as tariff jitters rattle banks

Bank of America stock steadies premarket after Monday’s drop as tariff jitters rattle banks

Bank of America shares were little changed in premarket trading Tuesday after closing down 3.75% amid a broad selloff in bank stocks. The KBW Regional Banking Index dropped 4.26% Monday as Treasury yields swung and investors weighed tariff headlines. JPMorgan, Wells Fargo, and Morgan Stanley each fell about 4%. U.S. stock futures edged higher early Tuesday ahead of key earnings and policy events.
24 February 2026
·······
Blue Owl stock price drops premarket after Deutsche Bank downgrade as private-credit jitters linger

Blue Owl stock price drops premarket after Deutsche Bank downgrade as private-credit jitters linger

Blue Owl Capital shares dropped 4.2% in premarket trading Tuesday after Deutsche Bank downgraded the stock to Hold and cut its price target to $10. The move follows rising investor concern over private-credit fund liquidity and exposure to software loans. Blue Owl has lost over 16% in five days amid headlines on fund withdrawals and a disputed financing issue tied to CoreWeave. Investors are watching for the March 2 dividend payment.
24 February 2026
·
Palantir stock price slides with software selloff; tariffs and Nvidia earnings set the next test

Palantir stock price slides with software selloff; tariffs and Nvidia earnings set the next test

Palantir shares fell 3.4% to $130.60 on Monday as investors sold off high-risk software stocks amid tariff uncertainty and renewed debate over AI disruption. U.S. stock indexes also declined, with software among the hardest hit. Traders are watching for Nvidia’s earnings report Wednesday, seen as the next major driver for AI-linked stocks. Futures edged higher early Tuesday, but markets remain volatile as tariff policy shifts.
24 February 2026
···
American Airlines stock slips before open as Northeast blizzard snarls flights and shelf filing hits tape

American Airlines stock slips before open as Northeast blizzard snarls flights and shelf filing hits tape

American Airlines shares fell 4.8% to $12.93 in premarket trading after a Northeast blizzard forced widespread flight cancellations. The company also filed a shelf registration late Monday, allowing for possible future sales of stock or debt. Operations resumed at Washington Reagan National and Philadelphia, with New York and Boston expected later Tuesday. Delta and United stocks also declined.
24 February 2026
···
Novo Nordisk stock slips again as CagriSema miss drives forecast cuts and puts next catalysts in focus

Novo Nordisk stock slips again as CagriSema miss drives forecast cuts and puts next catalysts in focus

Novo Nordisk shares fell 2.5% to 245.1 Danish crowns Tuesday after its CagriSema obesity drug failed to match Eli Lilly’s tirzepatide in a Phase 3 trial. Barclays cut its peak sales forecast for CagriSema to $2 billion from $12 billion. Novo also reported mid-stage China trial results for its “triple G” obesity drug UBT251, showing up to 19.7% weight loss after 24 weeks.
24 February 2026
··
Nvidia stock steadies in premarket as earnings loom and AI spend faces scrutiny

Nvidia stock steadies in premarket as earnings loom and AI spend faces scrutiny

Nvidia shares traded at $191.55, up 0.9%, ahead of quarterly results due Wednesday after the bell. Options markets signal a possible 6% swing in either direction, reflecting investor focus on AI demand, supply constraints, and China sales. Wall Street expects revenue to jump over 68% to $66.16 billion. The company will release results at 4:20 p.m. ET, with a conference call at 5 p.m.
24 February 2026
····
Gossamer Bio stock tumbles again premarket as Phase 3 PAH miss rewrites the story

Gossamer Bio stock tumbles again premarket as Phase 3 PAH miss rewrites the story

Gossamer Bio shares traded near $0.42 in early premarket Tuesday after plunging about 80% when its main drug failed to meet the primary goal in a Phase 3 trial. The company said the study’s key endpoint improved by 13.3 meters but did not reach statistical significance. Analysts downgraded the stock and flagged risks around funding and regulatory timelines. Gossamer plans to meet the FDA and paused another study.
24 February 2026
···
Shopify stock price slides 7% as tariff fog, AI jitters squeeze software names

Shopify stock price slides 7% as tariff fog, AI jitters squeeze software names

Shopify shares fell 7.1% to $117.28 on Monday, their steepest drop in weeks, as investors sold off software stocks amid U.S. tariff uncertainty and AI disruption fears. The S&P 500 software group slid 4.3%. U.S. Customs set a 10% tariff rate starting Tuesday, with a possible increase to 15% under discussion. No new Shopify announcements were made Monday.
24 February 2026
···
American Express stock tumbles 7% as “AI scare trade” hits payments; what to watch before the open

American Express stock tumbles 7% as “AI scare trade” hits payments; what to watch before the open

American Express shares fell 7.2% to $321.24, among the steepest drops on the Dow, after a weekend research note warned AI could disrupt card fees and spending. The decline was not linked to company earnings but sparked broader selling in payments stocks, with Visa and Capital One also down. Investors are watching upcoming U.S. data and Federal Reserve signals for further direction.
24 February 2026
····
1 … 212 213 214 215 216 … 1,953

Stock Market Today

  • Dr Martens Shares Rise on Profit Growth Amid Turnaround Signs
    May 19, 2026, 7:52 AM EDT. Dr Martens (LSE: DOCS) shares jumped nearly 6% after reporting a 61% rise in adjusted profit before tax (PBT) for fiscal year 2026, signaling a return to profit growth under CEO Ije Nwokorie. Despite an 84% share price drop since its 2021 IPO, the firm is shifting to a consumer-first model with strong brand collaborations and improved performance in the Americas. While management withheld specific guidance for FY27, analysts predict earnings growth could reduce the price-to-earnings ratio to 10 by 2028. The company maintains a 2.55p dividend, yielding 4%, reflecting cautious cash management amid supply chain cost controls. Investors are watching to see if this marks a sustainable turnaround for the iconic footwear brand.

Latest articles

MetaVia Stock Moves Ahead of the Open After Obesity-Drug Data Picked for ADA

MetaVia Stock Moves Ahead of the Open After Obesity-Drug Data Picked for ADA

19 May 2026
Diploma PLC shares rose 4.75% to 6,940p after the company raised its 2026 outlook, citing strong demand and a 17% rise in first-half revenue to £851.1 million. Adjusted operating profit climbed 33% to £208.9 million, and the interim dividend increased 5% to 19.1p. The Controls division posted 26% organic growth. Diploma completed 15 acquisitions worth about £310 million in the past year.
Zeta Global Pops Again as Traders Eye OpenAI Ad Deal

Zeta Global Pops Again as Traders Eye OpenAI Ad Deal

19 May 2026
Zeta Global shares rose 3.4% to $19.85 in premarket trading Tuesday after CEO David Steinberg announced an advertising agreement with OpenAI at a JPMorgan conference. The stock had closed up 11.6% at $19.19 on Monday, trading over 17 million shares. Bank of America reinstated coverage with a Buy rating and $24 target. Zeta recently reported first-quarter revenue up 50% year-over-year to $396 million.
Home Depot Earnings Show Housing Stress for Wall Street

Home Depot Earnings Show Housing Stress for Wall Street

19 May 2026
Home Depot reported first-quarter sales of $41.8 billion, up 4.8%, beating estimates, but comparable sales rose just 0.6%, missing analyst forecasts. Net earnings fell to $3.3 billion from $3.4 billion a year earlier. The company kept its 2026 outlook unchanged. Shares edged higher in premarket trading.

Popular

Roblox Shares Jump Almost 10%, Safety Issue Remains Unanswered

Roblox Shares Jump Almost 10%, Safety Issue Remains Unanswered

18 May 2026
Roblox shares rose 9.6% to $46.98 on Monday, bucking declines in the broader tech sector. The jump followed a month-long selloff tied to new child-safety measures, which the company says have reduced user communication and slowed new sign-ups. Roblox cut its 2026 bookings outlook on April 30, but first-quarter revenue and daily active users both rose over 35%. Analysts cited competition from Fortnite and the upcoming Grand Theft Auto VI.
Go toTop